Boc-Val-Cit-PAB-PNP
|
|
- CAS号:
- 870487-10-8
- 英文名:
- Boc-Val-Cit-PAB-PNP
- 英文别名:
- BOC-Val-cit-pab;Boc-Val-Cit-PAB-PNP;Boc-Val-Cit-PAB-PNB;Boc-Val-Cit-PABC-PNP;Benzeneethanol,6-iodo-;t-Butyloxycarbonyl-valyl-citrullyl-(4-aminobenzyl)-(4-nitrophenyl)carbonate;inhibit,Antibody-drug conjugates linkers,BocValCitPABPNP,ADC Linkers,Boc Val Cit PAB PNP,Inhibitor;4-[(S)-2-[(S)-2-(Boc-amino)-3-methylbutanamido]-5-ureidopentanamido]benzyl (4-Nitrophenyl) carbonate;L-Ornithinamide, N-[(1,1-dimethylethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]-;4-[[(2S)-2-[[(2S)-2-(tert-butoxycarbonylamino)-3-methyl-butanoyl]amino]-5-ureido-pentanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate
- 中文名:
- Boc-Val-Cit-PAB-PNP
- 中文别名:
- BOC-VAL-CIT-PAB-PNP 酯;化合物BOC-VAL-CIT-PAB-PNP;碳酸[(4-硝基苯基)]酯[4-[(S)-2-[(S)-2-(BOC-氨基)-3-甲基丁酰氨基]-5-脲基戊酰氨基]苄基]酯;N-[(1,1-二甲基乙氧基)羰基]-L-缬氨酰-N5-(氨基羰基)-N-[4-[[[(4-硝基苯氧基)羰基]氧基]甲基]苯基]-L-鸟氨酸;((S)-3-甲基-1-(((S)-1-((4-((((4-硝基苯氧基)羰基)氧基)甲基)苯基)氨基)-1-氧代-5-脲基戊烷-2-基)氨基)-1-氧代丁烷-2-基)氨基甲酸叔丁酯
- CBNumber:
- CB33172833
- 分子式:
- C30H40N6O10
- 分子量:
- 644.67
- MOL File:
- 870487-10-8.mol
|
|
|
Boc-Val-Cit-PAB-PNP化学性质
-
沸点:
-
896.0±65.0 °C(Predicted)
-
|
-
密度:
-
1.291±0.06 g/cm3(Predicted)
-
|
-
溶解度:
-
DMSO : 250 mg/mL (387.80 mM; Need ultrasonic)
-
|
-
酸度系数(pKa):
-
11.25±0.46(Predicted)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
White to off-white
-
|
Boc-Val-Cit-PAB-PNP性质、用途与生产工艺
Boc-Val-Cit-PAB-PNP 是一种可裂解 (cleavable) 的 ADC linker,可用于合成抗体偶联药物 (ADC)。
ADC由抗体组成,通过ADC接头将ADC细胞毒素与抗体结合。
Boc-Val-Cit-PAB-PNP 是一种可裂解的ADC linker,用于抗体偶联药物 (ADCs)的合成。
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
Boc-Val-Cit-PAB-PNP
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-141142 | Boc-Val-Cit-PAB-PNP Boc-Val-Cit-PAB-PNP | 870487-10-8 | 5mg | 300元 |
2024/04/30 | HY-141142 | Boc-Val-Cit-PAB-PNP Boc-Val-Cit-PAB-PNP | 870487-10-8 | 10mg | 450元 |
870487-10-8, Boc-Val-Cit-PAB-PNP 相关搜索:
- ADCs
- ADC LINKER
- Linker
- 化工试剂
- 药靶配体
- 生物试剂
- C30H40N6O10
- 碳酸[(4-硝基苯基)]酯[4-[(S)-2-[(S)-2-(BOC-氨基)-3-甲基丁酰氨基]-5-脲基戊酰氨基]苄基]酯
- ((S)-3-甲基-1-(((S)-1-((4-((((4-硝基苯氧基)羰基)氧基)甲基)苯基)氨基)-1-氧代-5-脲基戊烷-2-基)氨基)-1-氧代丁烷-2-基)氨基甲酸叔丁酯
- 化合物BOC-VAL-CIT-PAB-PNP
- N-[(1,1-二甲基乙氧基)羰基]-L-缬氨酰-N5-(氨基羰基)-N-[4-[[[(4-硝基苯氧基)羰基]氧基]甲基]苯基]-L-鸟氨酸
- BOC-VAL-CIT-PAB-PNP 酯
- 870487-10-8
- 4-[(S)-2-[(S)-2-(Boc-amino)-3-methylbutanamido]-5-ureidopentanamido]benzyl (4-Nitrophenyl) carbonate
- 4-[[(2S)-2-[[(2S)-2-(tert-butoxycarbonylamino)-3-methyl-butanoyl]amino]-5-ureido-pentanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate
- inhibit,Antibody-drug conjugates linkers,BocValCitPABPNP,ADC Linkers,Boc Val Cit PAB PNP,Inhibitor
- tert-Butyl ((S)-3-methyl-1-(((S)-1-((4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-1-oxobutan-2-yl)carbamate
- Benzeneethanol,6-iodo-
- t-Butyloxycarbonyl-valyl-citrullyl-(4-aminobenzyl)-(4-nitrophenyl)carbonate
- L-Ornithinamide, N-[(1,1-dimethylethoxy)carbonyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]-
- Boc-Val-Cit-PAB-PNB
- Boc-Val-Cit-PABC-PNP
- tert-butyl ((5)-3-methyl-1-(((5)-1-((4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-1-oxobutan-2-yl)carbamate
- BOC-Val-cit-pab
- Boc-Val-Cit-PAB-PNP